Cases of intravascular hemolysis and its complications have been reported in patients treated for immune thrombocytopenic purpura with WinRho.
WinRho SDF (Rho(D) Immune Globulin Intravenous (Human): Risk of Intravascular Hemolysis
March 10th, 2010 · No Comments
Tags: FDA · FDA Alerts
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.